Enhanced iSpecimen Marketplace® Platform with Data Integration Capabilities to Simplify the Ingestion and Maintenance of Biospecimen Inventories for...
LEXINGTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that...
New Suppliers Will Increase Access to Unique Banked Biospecimens for Advancing Oncology and Cardiovascular Disease Research...
Industry Veteran Brings Nearly Two Decades of Experience in Healthcare Product Management to the Company...
Company Gave Three Presentations, Including Oral Discussion on How New Technology Can Support the “Just-in-Time” Approach to Biobanking LEXINGTON, Mass.,...
LEXINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that...
LEXINGTON, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, online marketplace that...
Updated Interface Provides Improved Search and Data Integration Capabilities iSpecimen Marketplace Offers Millions of Biospecimens from Over 200 Providers...
The iSpecimen Marketplace Platform Now Provides Custom Sequencing for Cancer and COVID-19 Biofluid and Tissue Samples...
LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, proprietary online...